These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32399739)

  • 1. Molecular markers and targeted therapy in pediatric low-grade glioma.
    de Blank P; Fouladi M; Huse JT
    J Neurooncol; 2020 Oct; 150(1):5-15. PubMed ID: 32399739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.
    Haase S; Nuñez FM; Gauss JC; Thompson S; Brumley E; Lowenstein P; Castro MG
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Gliomas: Molecular Landscape and Emerging Targets.
    Peeters SM; Muftuoglu Y; Na B; Daniels DJ; Wang AC
    Neurosurg Clin N Am; 2021 Apr; 32(2):181-190. PubMed ID: 33781501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas.
    Garcia MA; Solomon DA; Haas-Kogan DA
    Future Oncol; 2016 Jun; 12(12):1493-506. PubMed ID: 27072750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas.
    Juratli TA; Qin N; Cahill DP; Filbin MG
    Pharmacol Ther; 2018 Feb; 182():70-79. PubMed ID: 28830841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric low-grade glioma in the era of molecular diagnostics.
    Ryall S; Tabori U; Hawkins C
    Acta Neuropathol Commun; 2020 Mar; 8(1):30. PubMed ID: 32164789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
    Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA
    Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.
    Ryall S; Krishnatry R; Arnoldo A; Buczkowicz P; Mistry M; Siddaway R; Ling C; Pajovic S; Yu M; Rubin JB; Hukin J; Steinbok P; Bartels U; Bouffet E; Tabori U; Hawkins C
    Acta Neuropathol Commun; 2016 Aug; 4(1):93. PubMed ID: 27577993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas.
    Dasgupta T; Haas-Kogan DA
    Front Oncol; 2013; 3():110. PubMed ID: 23717811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment.
    Rizzo D; Ruggiero A; Martini M; Rizzo V; Maurizi P; Riccardi R
    Biomed Res Int; 2015; 2015():215135. PubMed ID: 26448930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era.
    Manoharan N; Liu KX; Mueller S; Haas-Kogan DA; Bandopadhayay P
    Neoplasia; 2023 Feb; 36():100857. PubMed ID: 36566593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Pediatric Low-Grade Gliomas.
    Sait SF; Giantini-Larsen AM; Tringale KR; Souweidane MM; Karajannis MA
    Curr Neurol Neurosci Rep; 2023 Apr; 23(4):185-199. PubMed ID: 36881254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF Mutations in CNS Tumors-Prognostic Markers and Therapeutic Targets.
    Muniz TP; Mason WP
    CNS Drugs; 2023 Jul; 37(7):587-598. PubMed ID: 37268805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigational new drugs for brain cancer.
    Staedtke V; Bai RY; Laterra J
    Expert Opin Investig Drugs; 2016 Aug; 25(8):937-56. PubMed ID: 27170161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric low-grade gliomas: how modern biology reshapes the clinical field.
    Bergthold G; Bandopadhayay P; Bi WL; Ramkissoon L; Stiles C; Segal RA; Beroukhim R; Ligon KL; Grill J; Kieran MW
    Biochim Biophys Acta; 2014 Apr; 1845(2):294-307. PubMed ID: 24589977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy.
    Graham MS; Mellinghoff IK
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.